The U.S. Food and Drug Administration has approved Opzelura cream 1.5% (ruxolitinib) for children ages 2 to 11 years with ...

Panelists discuss how successful access initiatives include integrated specialty pharmacies, community-based clinics, clinical trial opportunities, telehealth services, and financial assistance ...

The FDA approved a supplemental new drug application for ruxolitinib cream 1.5% for the short-term and noncontinuous ...

Ruxolitinib cream received an expanded approval to treat patients as young as 2 years old with non-immunocompromised mild to severe atopic dermatitis. Ruxolitinib cream (Opzelura; Incyte), a topical ...

This review focuses on the pathogenesis, influencing factors, limitations of current treatments, and recent advances in the application of natural extracts for atopic dermatitis (AD). The authors ...

A position paper argues that any systemic corticosteroid exposure in atopic dermatitis should trigger a transition to ...

Let’s be real: When it comes to detecting heart disease risk, you probably aren’t checking your skin first. And why would you? Skin health and heart health are unrelated, right? Not quite, doctors say ...

Adults with atopic dermatitis, whether diagnosed during childhood or adulthood, experienced higher rates of suicidal thoughts ...

Perioral dermatitis is a skin condition that can make you feel frustrated and confused at the same time, causing red bumps, ...

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on ...

We spoke to dermatologists and conducted research to pick the best lotions for eczema, including picks from brands like ...

It can be hard to feel good about your skin care routine when so many products come in plastic and you’re constantly pushed ...